Dataset Information

Economic benefits of blast-resistant biofortified wheat in Bangladesh: The case of BARI Gom 33.

ABSTRACT: The first occurrence of wheat blast in 2016 threatened Bangladesh's already precarious food security situation. The Bangladesh Agricultural Research Institute (BARI), together with the International Maize and Wheat Improvement Center (CIMMYT) developed and released the wheat variety BARI Gom 33 that is resistant to wheat blast and other common diseases. The new variety provides a 5-8% yield gain over the available popular varieties, as well as being zinc enriched. This study examines the potential economic benefits of BARI Gom 33 in Bangladesh. First, applying a climate analogue model, this study identified that more than 55% of the total wheat-growing area in Bangladesh (across 45 districts) is vulnerable to wheat blast. Second, applying an ex-ante impact assessment framework, this study shows that with an assumed cumulative adoption starting from 2019-20 and increasing to 30% by 2027-28, the potential economic benefits of the newly developed wheat variety far exceeds its dissemination cost by 2029-30. Even if dissemination of the new wheat variety is limited to only the ten currently blast-affected districts, the yearly average net benefits could amount to USD 0.23-1.6 million. Based on the findings, international funder agencies are urged to support the national system in scaling out the new wheat variety and wheat research in general to ensure overall food security in Bangladesh and South Asia.

SUBMITTER: Mottaleb KA

PROVIDER: S-EPMC6686726 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Economic benefits of blast-resistant biofortified wheat in Bangladesh: The case of <i>BARI Gom 33</i>.

Mottaleb Khondoker A KA Govindan Velu V Singh Pawan K PK Sonder Kai K He Xinyao X Singh Ravi P RP Joshi Arun K AK Barma Naresh C D NCD Kruseman Gideon G Erenstein Olaf O

Crop Protection. 20190901

The first occurrence of wheat blast in 2016 threatened Bangladesh's already precarious food security situation. The Bangladesh Agricultural Research Institute (BARI), together with the International Maize and Wheat Improvement Center (CIMMYT) developed and released the wheat variety <i>BARI Gom</i> 33 that is resistant to wheat blast and other common diseases. The new variety provides a 5-8% yield gain over the available popular varieties, as well as being zinc enriched. This study examines the ...[more]

PMID: 31481821

Similar Datasets

Project description:Respiratory syncytial virus (RSV) infection is a major cause of morbidity in children. However, its disease burden remains poorly understood, particularly outside of the hospital setting. Our study aimed to estimate the burden of medically attended acute lower respiratory infection (ALRI) cases potentially related to RSV in Spanish children. Longitudinal data from September 2017 to June 2018 of 51,292 children aged < 5 years old from the National Healthcare System (NHS) of two Spanish regions were used. Three case definitions were considered: (a) RSV-specific; (b) RSV-specific and unspecified acute bronchiolitis (RSV-specific and Bronchiolitis), and; (c) RSV-specific and unspecified ALRI (RSV-specific and ALRI). A total of 3460 medically attended ALRI cases potentially due to RSV were identified, of which 257 (7.4%), 164 (4.7%), and 3039 (87.8%) coded with RSV-specific, unspecific bronchiolitis, and unspecific ALRI codes, respectively. Medically attended RSV-specific and ALRI cases per 1000 children was 134.4 in the first year of life, 119.4 in the second, and 35.3 between 2 and 5 years old. Most cases were observed in otherwise healthy children (93.1%). Mean direct healthcare cost per medically attended RSV-specific and ALRI case was €1753 in the first year of life, €896 in the second, and €683 between 2 and 5 years old. Hospitalization was the main driver of these costs, accounting for 55.6%, 38.0% and 33.4%, in each respective age group. In RSV-specific cases, mean direct healthcare cost per medically attended case was higher, mostly due to hospitalization: €3362 in the first year of life (72.9% from hospitalizations), €3252 in the second (72.1%), and €3514 between 2 and 5 years old (74.2%). These findings suggest that hospitalization data alone will underestimate the RSV infections requiring medical care, as will relying only on RSV-specific codes. RSV testing and codification must be improved and preventive solutions adopted, to protect all infants, particularly during the first year of life.

Dataset Information

Economic benefits of blast-resistant biofortified wheat in Bangladesh: The case of BARI Gom 33.

Publications

Economic benefits of blast-resistant biofortified wheat in Bangladesh: The case of <i>BARI Gom 33</i>.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets